Skip to content

‘An Enemy of the People’ revival recoups investment

The production is nominated for five 2024 Tony Awards.

Jeremy Strong in “An Enemy of the People” on Broadway, 2024 (Credit: Emilio Madrid)

“An Enemy of the People” has recouped its $5.5 million investment. The revival of Henrik Ibsen’s 1882 classic, in a new adaptation by Amy Herzog, began previews on Feb. 27 and opened on March 18 at Broadway’s Circle in the Square Theatre. The extended production, directed by Sam Gold, is scheduled to run through June 23.

The cast of “An Enemy of the People” includes Jeremy Strong, Michael Imperioli, Victoria Pedretti, Katie Broad, Bill Buell, Joe Cassidy, Caleb Eberhardt, Matthew August Jeffers, David Patrick Kelly, David Mattar Merten, Max Roll, Thomas Jay Ryan and Alan Trong. The production is nominated for five 2024 Tony Awards, including a Best Revival of a Play, as well as a nod for Strong.

Since beginning previews, “An Enemy of the People” has played to over 100% capacity every week (through the week ending June 2). The production also holds the distinction of being the only show to earn over $1 million in a single week in the 52-year history of the Circle of the Square Theatre. As of the week ending June 2, the revival has surpassed the weekly $1 million benchmark a dozen times.

“An Enemy of the People” tells the story of doctor Thomas Stockmann (Strong), who discovers that the waters of a Norwegian town’s new spa resort are contaminated. His efforts to make the news public are challenged by those in power, namely his brother, the town’s mayor, Peter Stockmann (Imperioli).

“An Enemy of the People” is produced by Seaview, Patrick Catullo, and Plan B.